← 產業報告目錄
mRNA Post-Transcriptional Enzymatic Capping Market Share & Trends Analysis Report, By Product Type (Capping Enzymes, Capping Kits, Reagents and Consumables, Custom mRNA Synthesis Services), By Application (mRNA Vaccines, mRNA Therapeutics, Research Tools, Emerging Applications), By End-User, By Region, and Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-13頁數 170報告編號 INSIGHTACE-db5a24bf6d
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The global mRNA Post-Transcriptional Enzymatic Capping Market is poised to increase at a compound annual growth rate of 6.8% throughout the 2025–2034 forecast period. MRNA Post-Transcriptional Enzymatic Capping encompasses The process of adding a 5′ cap structure to messenger RNA (mRNA) via in vitro transcription (IVT) using enzymes such as RNA triphosphatase, guanylyltransferase, and methyltransferases is known a. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
The market's upward path is propelled by expanding healthcare spending, technological evolution, and the expanding focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region poised to deliver the strongest growth trajectory through the forecast period, propelled by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global mRNA Post-Transcriptional Enzymatic Capping Market Snapshot
Chapter 4. Global mRNA Post-Transcriptional Enzymatic Capping Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on mRNA Post-Transcriptional Enzymatic Capping Market Industry Trends
4.10. Global mRNA Post-Transcriptional Enzymatic Capping Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. mRNA Post-Transcriptional Enzymatic Capping Market Segmentation 1: By Product Type, Estimates & Trend Analysis
5.1. Market Share by Product Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:
5.2.1. Capping Enzymes
5.2.2. 2′-O-Methyltransferase
5.2.3. Capping Kits
5.2.4. Custom mRNA Services
Chapter 6. mRNA Post-Transcriptional Enzymatic Capping Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. mRNA Vaccines
6.2.2. mRNA Therapeutics
6.2.3. Research Tools
6.2.4. Emerging Applications (saRNA, circRNA)
Chapter 7. mRNA Post-Transcriptional Enzymatic Capping Market Segmentation 3: By End-User, Estimates & Trend Analysis
7.1. Market Share by End-User, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:
7.2.1. Pharmaceutical & Biotechnology Companies
7.2.2. Contract Development & Manufacturing Organizations (CDMOs)
7.2.3. Academic & Research Institutes
7.2.4. Contract Research Organizations (CROs)
Chapter 8. mRNA Post-Transcriptional Enzymatic Capping Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global mRNA Post-Transcriptional Enzymatic Capping Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.2.3. North America mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.4. North America mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
8.3. Europe
8.3.1. Europe mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.3.3. Europe mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.4. Europe mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.4.3. Asia Pacific mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.4. Asia Pacific mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
8.5. Latin America
8.5.1. Latin America mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.5.3. Latin America mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.4. Latin America mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.6.3. Middle East & Africa mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.6.4. Middle East & Africa mRNA Post-Transcriptional Enzymatic Capping Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. New England Biolabs (NEB)
9.2.1.1. Business Overview
9.2.1.2. Key Product Type/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Takara Bio Inc.
9.2.3. Canvax Biotech
9.2.4. CELLSCRIPT
9.2.5. Thermo Fisher Scientific
9.2.6. Aldevron
9.2.7. KACTUS
9.2.8. Creative Biolabs
9.2.9. Jena Bioscience
9.2.10. Promega Corporation
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們